glp 1 incretin mimetics PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Incretins Incretin Mimetics Side Effects -

Glucagon-like peptide-1 (GLP-1) receptor agonists aka the -tides, GLP analogs, incretin mimetics *The FDA has approved the use of -glutides to reduce the risk of major cardiovascular events (myocardial infarction, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors

Either way, it has proven effective in lowering blood sugar for people with Type 2 diabetes

The changes observed in cysteine and glutathione were of a magnitude comparable to differences previously observed between autistic and neurotypical children, implying potential biological relevance

Epub 2019 Mar 9 PMID: 30862544

doi: 10.3109/10715762.2011.555765